Published preclinical studies have examined BPC-157 across gastrointestinal tissue (NSAID-induced injury, alcohol-induced damage, inflammatory bowel models) (1), tendon and connective tissue (5)(2), muscle and bone models (1), and neurological tissue through brain-gut axis interactions (4)
Nu Image Medical may not offer the medications or services mentioned in this article.
How BPC-157 (Oral) Works Oral BPC-157 acts primarily through local gastrointestinal mechanisms and, to a debated extent, through systemic absorption from the gut
This may cause cloudiness, visible particles, clumping, foaming, gel formation, aggregation, or precipitation
2 The committee voted the other way on six of them
It is not intended as a standalone therapeutic dose for severe B12 deficiency, which would require separate supplementation at different intervals and doses under veterinary guidance